Powell Fred M 4
4 · ANTARES PHARMA, INC. · Filed Jun 14, 2021
Insider Transaction Report
Form 4
Powell Fred M
Senior Vice President & CFO
Transactions
- Tax Payment
Common Stock
2021-06-13$4.45/sh−11,880$52,866→ 761,652 total - Award
Stock Option (right to buy)
2021-06-10+163,963→ 163,963 totalExercise: $4.42Exp: 2031-06-10→ Common Stock (163,963 underlying) - Award
Common Stock
2021-06-10$4.42/sh+85,973$380,001→ 790,859 total - Tax Payment
Common Stock
2021-06-13$4.45/sh−17,327$77,105→ 773,532 total
Footnotes (4)
- [F1]Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest in three equal annual installments from the date of grant.
- [F2]Represents the payment of tax liability using a portion of securities received from the company in connection with the vesting of a previously granted restricted stock unit award. The shares of common stock reported herein were withheld by the company to cover tax liability and not actually sold.
- [F3]Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan.
- [F4]The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date.